Polymorphisms in oxidative stress-related genes and postmenopausal breast cancer risk

International Journal of Cancer

Volumn 129, Issue 6, 2011, Pages 1467-1476

  Seibold, Petra ^a   Hein, Rebecca ^a   Schmezer, Peter ^a   Hall, Per ^b   Liu, Jianjun ^c   Dahmen, Norbert ^d   Flesch Janys, Dieter ^e   Popanda, Odilia ^a   Chang Claude, Jenny ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c GENOME INSTITUTE OF SINGAPORE   (Singapore)

^d Genome Institute of Singapore ^*  (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

antioxidant defense enzymes; case control study; genetic polymorphisms; genetic susceptibility; joint analysis; thioredoxin

Indexed keywords

METALLOTHIONEIN II; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THIOREDOXIN; THIOREDOXIN 2;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CONTROLLED STUDY; CYBA GENE; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MT2A GENE; ONCOGENE; OXIDATIVE STRESS; POPULATION BASED CASE CONTROL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TXN GENE; TXN2 GENE;

BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; RISK ASSESSMENT;

EID: 79960906274     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25761     Document Type: Article

References (50)

1. Robert Koch Institute. Cancer in Germany 2003-2004. Incidence and trends, 6th edn. Berlin, 2008.
2. Halliwell B,. Oxidative stress and cancer: have we moved forward? Biochem J 2007; 401: 1-11. (Pubitemid 46115897)
3. Karihtala P, Soini Y,. Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. APMIS 2007; 115: 81-103. (Pubitemid 46208084)
4. Weinberg F, Chandel NS,. Reactive oxygen species-dependent signaling regulates cancer. Cell Mol Life Sci 2009; 66: 3663-73.
5. Forsberg L, de FU, Morgenstern R,. Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys 2001; 389: 84-93. (Pubitemid 32911546)
6. Kim YS, Morgan MJ, Choksi S, Liu ZG,. TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol Cell 2007; 26: 675-87. (Pubitemid 46856240)
7. Kang YJ,. Metallothionein redox cycle and function. Exp Biol Med (Maywood) 2006; 231: 1459-67. (Pubitemid 44547837)
8. Nordberg J, Arner ES,. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 2001; 31: 1287-312. (Pubitemid 33145299)
9. Townsend DM, Tew KD, Tapiero H,. The importance of glutathione in human disease. Biomed Pharmacother 2003; 57: 145-55. (Pubitemid 36740460)
10. McIlwain CC, Townsend DM, Tew KD,. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 2006; 25: 1639-48.
11. Arrigo AP, Virot S, Chaufour S, Firdaus W, Kretz-Remy C, az-Latoud C,. Hsp27 consolidates intracellular redox homeostasis by upholding glutathione in its reduced form and by decreasing iron intracellular levels. Antioxid Redox Signal 2005; 7: 414-22.
12. Winterbourn CC, Vissers MC, Kettle AJ,. Myeloperoxidase. Curr Opin Hematol 2000; 7: 53-8. (Pubitemid 30007688)
13. Mikkelsen RB, Wardman P,. Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene 2003; 22: 5734-54. (Pubitemid 37176697)
14. Takahashi T, Shimizu H, Morimatsu H, Inoue K, Akagi R, Morita K, Sassa S,. Heme oxygenase-1: a fundamental guardian against oxidative tissue injuries in acute inflammation. Mini Rev Med Chem 2007; 7: 745-53. (Pubitemid 47099174)
15. Siegel D, Gustafson DL, Dehn DL, Han JY, Boonchoong P, Berliner LJ, Ross D,. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger. Mol Pharmacol 2004; 65: 1238-47. (Pubitemid 38543494)
16. Flesch-Janys D, Slanger T, Mutschelknauss E, Kropp S, Obi N, Vettorazzi E, Braendle W, Bastert G, Hentschel S, Berger J, Chang-Claude J,. Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy. Int J Cancer 2008; 123: 933-41. (Pubitemid 352032424)
17. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA,. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004; 74: 106-20. (Pubitemid 38085242)
18. Olsen A, Autrup H, Sorensen M, Overvad K, Tjonneland A,. Polymorphisms of glutathione S-transferase A1 and O1 and breast cancer among postmenopausal Danish women. Eur J Cancer Prev 2008; 17: 225-9. (Pubitemid 351549662)
19. Andonova IE, Justenhoven C, Winter S, Hamann U, Baisch C, Rabstein S, Spickenheuer A, Harth V, Pesch B, Bruning T, Ko YD, Ganev V, et al. No evidence for glutathione S-transferases GSTA2, GSTM2, GSTO1, GSTO2, and GSTZ1 in breast cancer risk. Breast Cancer Res Treat 2010; 121: 497-502.
20. Hefler LA, Grimm C, Lantzsch T, Lampe D, Koelbl H, Lebrecht A, Heinze G, Tempfer C, Reinthaller A, Zeillinger R,. Polymorphisms of the endothelial nitric oxide synthase gene in breast cancer. Breast Cancer Res Treat 2006; 98: 151-5. (Pubitemid 44050763)
21. Royo JL, Moreno-Nogueira JA, Galan JJ, Gonzalez-Martin A, Ruiz A, Gonzalez-Mancha R, Real LM,. Lack of association between NOS3 Glu298Asp and breast cancer risk: a case-control study. Breast Cancer Res Treat 2006; 100: 331-3. (Pubitemid 44707928)
22. Menzel HJ, Sarmanova J, Soucek P, Berberich R, Grunewald K, Haun M, Kraft HG,. Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations. Br J Cancer 2004; 90: 1989-94. (Pubitemid 38746342)
23. Hong CC, Ambrosone CB, Ahn J, Choi JY, McCullough ML, Stevens VL, Rodriguez C, Thun MJ, Calle EE,. Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2007; 16: 1784-94. (Pubitemid 47450508)
24. Ambrosone CB, Freudenheim JL, Thompson PA, Bowman E, Vena JE, Marshall JR, Graham S, Laughlin R, Nemoto T, Shields PG,. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res 1999; 59: 602-6. (Pubitemid 29076057)
25. Cox A, Dunning AM, Garcia-Closas M, Balasubramanian S, Reed MW, Pooley KA, Scollen S, Baynes C, Ponder BA, Chanock S, Lissowska J, Brinton L, et al. A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 2007; 39: 352-8. (Pubitemid 46328496)
26. Morel F, Rauch C, Coles B, Le FE, Guillouzo A,. The human glutathione transferase alpha locus: genomic organization of the gene cluster and functional characterization of the genetic polymorphism in the hGSTA1 promoter. Pharmacogenetics 2002; 12: 277-86. (Pubitemid 34620655)
27. The International HapMap Consortium. The International HapMap Project. Nature 2003; 426: 789-96.
28. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D,. Efficiency and power in genetic association studies. Nat Genet 2005; 37: 1217-23. (Pubitemid 41568704)
29. Shen R, Fan JB, Campbell D, Chang W, Chen J, Doucet D, Yeakley J, Bibikova M, Wickham GE, McBride C, Steemers F, Garcia F, et al. High-throughput SNP genotyping on universal bead arrays. Mutat Res 2005; 573: 70-82. (Pubitemid 40514402)
30. Skol AD, Scott LJ, Abecasis GR, Boehnke M,. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006; 38: 209-13. (Pubitemid 43177235)
31. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, Defelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-9. (Pubitemid 34680308)
32. Chen B, Wilkening S, Drechsel M, Hemminki K,. SNP-tools: A compact tool package for analysis and conversion of genotype data for MS-Excel. BMC Res Notes 2009; 2: 214.
33. Lake SL, Lyon H, Tantisira K, Silverman EK, Weiss ST, Laird NM, Schaid DJ,. Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 2003; 55: 56-65. (Pubitemid 36928747)
34. Cebrian A, Pharoah PD, Ahmed S, Smith PL, Luccarini C, Luben R, Redman K, Munday H, Easton DF, Dunning AM, Ponder BA,. Tagging single-nucleotide polymorphisms in antioxidant defense enzymes and susceptibility to breast cancer. Cancer Res 2006; 66: 1225-33. (Pubitemid 43165994)
35. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, Wacholder S, Wang Z, Welch R, Hutchinson A, Wang J, Yu K, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007; 39: 870-4. (Pubitemid 47014500)
36. Einarsdottir K, Darabi H, Li Y, Low YL, Li YQ, Bonnard C, Sjolander A, Czene K, Wedren S, Liu ET, Hall P, Humphreys K, et al. ESR1 and EGF genetic variation in relation to breast cancer risk and survival. Breast Cancer Res 2008; 10: R15.
37. Schwarzer G,. Meta: Meta-Analysis. R package version 0.9-15. 2008.
38. Lumley T,. rmeta: Meta-Analysis. R package version 2.15. 2009.
39. Dersimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88. (Pubitemid 17189972)
40. Arner ES, Holmgren A,. The thioredoxin system in cancer. Semin Cancer Biol 2006; 16: 420-6. (Pubitemid 44780139)
41. Cha MK, Suh KH, Kim IH,. Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma. J Exp Clin Cancer Res 2009; 28: 93.
42. San JG, Fortuno A, Beloqui O, Diez J, Zalba G,. NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases. Clin Sci (Lond) 2008; 114: 173-82. (Pubitemid 351293993)
43. Lan Q, Zheng T, Shen M, Zhang Y, Wang SS, Zahm SH, Holford TR, Leaderer B, Boyle P, Chanock S,. Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma. Hum Genet 2007; 121: 161-8. (Pubitemid 46404450)
44. Wyche KE, Wang SS, Griendling KK, Dikalov SI, Austin H, Rao S, Fink B, Harrison DG, Zafari AM,. C242T CYBA polymorphism of the NADPH oxidase is associated with reduced respiratory burst in human neutrophils. Hypertension 2004; 43: 1246-51. (Pubitemid 38696914)
45. Van Der Logt EM, Janssen CH, Van HZ, Roelofs HM, Wobbes T, Nagengast FM, Peters WH,. No association between genetic polymorphisms in NAD(P)H oxidase p22phox and paraoxonase 1 and colorectal cancer risk. Anticancer Res 2005; 25: 1465-70. (Pubitemid 40546830)
46. Cherian MG, Jayasurya A, Bay BH,. Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res 2003; 533: 201-9. (Pubitemid 37487869)
47. Pedersen MO, Larsen A, Stoltenberg M, Penkowa M,. The role of metallothionein in oncogenesis and cancer prognosis. Prog Histochem Cytochem 2009; 44: 29-64.
48. Zhang R, Zhang H, Wei H, Luo X,. Expression of metallothionein in invasive ductal breast cancer in relation to prognosis. J Environ Pathol Toxicol Oncol 2000; 19: 95-7. (Pubitemid 33021290)
49. Wacholder S, Hartge P, Prentice R, Garcia-Closas M, Feigelson HS, Diver WR, Thun MJ, Cox DG, Hankinson SE, Kraft P, Rosner B, Berg CD, et al. Performance of common genetic variants in breast-cancer risk models. N Engl J Med 2010; 362: 986-93.
50. Cadenas C, Franckenstein D, Schmidt M, Gehrmann M, Hermes M, Geppert B, Schormann W, Maccoux LJ, Schug M, Schumann A, Wilhelm C, Freis E, et al. Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer. Breast Cancer Res 2010; 12: R44.